|
POLB expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.462300E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.229800E-02 |
| Normal-vs-Stage2 |
5.261000E-01 |
| Normal-vs-Stage3 |
3.950200E-01 |
| Normal-vs-Stage4 |
9.370000E-02 |
| Stage1-vs-Stage2 |
4.607200E-01 |
| Stage1-vs-Stage3 |
4.822000E-01 |
| Stage1-vs-Stage4 |
6.967400E-01 |
| Stage2-vs-Stage3 |
8.953200E-01 |
| Stage2-vs-Stage4 |
3.160600E-01 |
| Stage3-vs-Stage4 |
3.324200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.997700E-02 |
| Normal-vs-AfricanAmerican |
2.594000E-01 |
| Normal-vs-Asian |
7.471000E-01 |
| Caucasian-vs-AfricanAmerican |
3.767400E-01 |
| Caucasian-vs-Asian |
6.086000E-01 |
| AfricanAmerican-vs-Asian |
7.682200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.029700E-02 |
| Normal-vs-Female |
9.797200E-01 |
| Male-vs-Female |
1.544130E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.736820E-01 |
| Normal-vs-Extreme_Weight |
1.009610E-01 |
| Normal-vs-Obese |
1.431800E-01 |
| Normal-vs-Extreme_Obese |
2.081800E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.575000E-01 |
| Normal_Weight-vs-Obese |
9.757600E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.952990E-01 |
| Extreme_Weight-vs-Obese |
7.414200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.020200E-01 |
| Obese-vs-Extreme_Obese |
1.281950E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.614800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.756220E-01 |
| Normal-vs-Age(61-80Yrs) |
4.907900E-02 |
| Normal-vs-Age(81-100Yrs) |
1.459670E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.768950E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.427370E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.339500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.199200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.736100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.855000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.647800E-02 |
| Normal-VS-Type2 PRCC |
4.971500E-02 |
| Normal-VS-KIRP CIMP |
4.361400E-01 |
| Normal-VS-Unclassified PRCC |
8.846000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
7.186000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.841600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.996200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.543300E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
8.243000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.220260E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.701700E-02 |
| Normal-vs-N1 |
9.789400E-01 |
| Normal-vs-N2 |
2.244000E-01 |
| N0-vs-N1 |
2.805800E-02 |
| N0-vs-N2 |
4.537600E-01 |
| N1-vs-N2 |
8.275500E-02 |
|
|
